Prokocimer Philippe 4
4 · Trius Therapeutics Inc · Filed May 15, 2013
Insider Transaction Report
Form 4
Prokocimer Philippe
Chief Medical Officer
Transactions
- Sale
Common Stock
2013-05-13$7.65/sh−12,000$91,800→ 86,022 total(indirect: By Trust)
Holdings
- 10,429
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012
- [F2]Includes 396 and 534 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 5/18/12 and 11/20/12, respectively.